E-LIB Suche - Ergebnisse für: Secord, A.A.

1

38MO Progression-free survival (PFS) in primary advanced or..:

Mirza, M.R. ; Ghamande, S. ; Hanker, L.C....
ESMO Open. 9 (2024) - p. 103538 , 2024

Link: https://doi.org/10.1016/..

2

A systematic outpatient quality improvement intervention re..:

Puechl, A.M. ; Lim, S. ; Gatta, L.A....
Gynecologic Oncology. 159 (2020) - p. 306 , 2020

Link: https://doi.org/10.1016/..

3

Just OK is not OK: How well does PARP inhibitor frontline m..:

Gonzalez, R. ; Havrilesky, L.J. ; Secord, A.A....
Gynecologic Oncology. 159 (2020) - p. 21-22 , 2020

Link: https://doi.org/10.1016/..

4

Randomized phase II trial of carboplatin-paclitaxel compare..:

Fader, A.N. ; Roque, D.M. ; Siegel, E.R....
Gynecologic Oncology. 159 (2020) - p. 7-8 , 2020

Link: https://doi.org/10.1016/..

5

Adjuvant treatment in high intermediate risk early stage en..:

Son, J. ; Carr, C. ; Chambers, L. Moulton...
Gynecologic Oncology. 156 (2020) 3 - p. e10 , 2020

Link: https://doi.org/10.1016/..

6

Safety and Efficacy Results of Retreatment With a PARP Inhi..:

Rimel, B.J. ; Secord, A.A. ; Geller, M.A....
Gynecologic Oncology. 156 (2020) 3 - p. e4-e5 , 2020

Link: https://doi.org/10.1016/..

7

The gynecologic oncology patient experience with oral anti-..:

Watson, C.H. ; Fish, L. ; Havrilesky, L.J...
Gynecologic Oncology. 159 (2020) - p. 285 , 2020

Link: https://doi.org/10.1016/..

8

A randomized phase II evaluation of weekly gemcitabine plus..:

Duska, L.R. ; Petroni, G.R. ; Varhegyi, N....
Gynecologic Oncology. 157 (2020) 3 - p. 585-592 , 2020

Link: https://doi.org/10.1016/..

9

A randomized phase II evaluation of weekly gemcitabine plus..:

Duska, L.R. ; Petroni, G. ; Brown, J....
Gynecologic Oncology. 159 (2020) - p. 15 , 2020

Link: https://doi.org/10.1016/..

10

Pembrolizumab window study: Illuminating the immunologic la..:

Gaillard, S. ; Broadwater, G. ; Andrews, W.S....
Gynecologic Oncology. 159 (2020) - p. 41 , 2020

Link: https://doi.org/10.1016/..

11

Molecular driven endometrial cancer therapy (MODEL): A pros..:

Secord, A.A. ; Previs, R.A. ; Pothuri, B....
Gynecologic Oncology. 154 (2019) - p. 248 , 2019

Link: https://doi.org/10.1016/..

12

Early-stage endometrial cancer with lymphovascular space in..:

Yen, T.T. ; Beavis, A.L. ; Stone, R.L....
Gynecologic Oncology. 154 (2019) - p. 287-288 , 2019

Link: https://doi.org/10.1016/..

13

Baseline platelet count and body weight as predictors of ea..:

Matulonis, U.A. ; Monk, B.J. ; Secord, A.A....
Gynecologic Oncology. 154 (2019) - p. 3 , 2019

Link: https://doi.org/10.1016/..

14

Rate of venous thromboembolism during neoadjuvant chemother..:

Salinaro, J.R. ; Boccaccio, R.B. ; Ehrisman, J.A....
Gynecologic Oncology. 154 (2019) - p. 29-30 , 2019

Link: https://doi.org/10.1016/..

15

Maintenance therapy utilization in platinum-sensitive recur..:

Moss, H.A. ; Havrilesky, L.J. ; Kauff, N.D..
Gynecologic Oncology. 154 (2019) - p. 204 , 2019

Link: https://doi.org/10.1016/..